BDX

Becton, Dickinson and Co.
Data: 2026-03-30
$154.69
Price
0.12%
Change
$229.7975
52W High
$153.18
52W Low

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Quick Stats
Mar 30, 2026

64.2

AI Score

BUY

0.72

Volume Ratio

May 07, 2026

Next Earnings

9

+ve Days (30d)

21

-ve Days (30d)

BDX Stock Summary

Last updated Mar 30, 2026

BDX is currently trading at $154.69, positioned below its 200-day moving average of $185.83, suggesting bearish momentum. The stock has a 52-week range of $153.18 to $229.7975.

Technical Analysis: The 50-day moving average stands at $180.23, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 27.931, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.193, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BDX at 64.2/100 with a BUY recommendation.

BDX (Becton, Dickinson and Co.) Indicators

Last updated Mar 30, 2026

Indicator Value
RSI(14) 27.931
CMF (20) -0.193
ROC (10) -3.993
ADX (14) 43.575
Indicator Value
MACD (12,26,9) -6.995
AROONOSC (14) -100.0
WILLAMS %R (14) -93.681
MFI (14) 32.049
BDX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BDX Price vs Max Options Open Interest
BDX Max Change In Options Open Interest

BDX Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BDX Daily Out of Money Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BDX Daily In the Money Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BDX Most Active Options by Volume(near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Becton, Dickinson and Co. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

BDX Moving Averages Analysis

BDX (Becton, Dickinson and Co.) Simple Moving Averages

Moving Averages are last updated Mar 30, 2026

Days MA
10 156.74
20 161.1
30 167.58
50 180.23
100 187.28
200 185.83

BDX Fundamental Analysis

P/E (Forward) 12.6103
P/E (Trailing) 25.7157
Market Cap ($) 57.0 billion
Earnings/Share ($) 6.12
Net Proft Margin (%) 0.0801
Dividend/Share ($) 4.17
EPS Estimate Current Year ($) 12.4575
EPS Estimate Next Year ($) 13.5133
WallStreet Target Price ($) 196.0833
Most Recent Quarter